Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Schütz Family Office
ViennaSeed–Growth$1.1M
7 people
Seido Capital
BrusselsPre-Seed–Series B$270K – $2.7M
7 people
Split Rock Partners
Eden PrairieSeed–Growth$2M – $40M
4 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
BlueStone Venture Partners
TucsonSeed–Series B$250K – $1M
4 people
Birch Venture Capital, Inc.
Taipei CitySeed–Late Stage
3 people
Mitsui Sumitomo Insurance Capital
TokyoPre-Seed–Growth
3 people
Aditum Bio
OaklandSeries A–Series B
8 people
Kern Capital, LLC
LarkspurSeries A–Late Stage$5M – $15M
1 person
Global BioAccess Fund
New YorkSeries A–Late Stage$10M
7 people
Salvia
HolzkirchenSeed–Series B
4 people
TiVenture SA
LuganoPre-Seed–Series B
4 people
Marram Ventures
SaugatuckSeed–Series B$3M
3 people
MSA Capital
Grand CaymanPre-Seed–Late Stage
6 people
DBH Investment Zrt.
BudapestSeed–Series B$216K – $1.6M
7 people
Northern Light Venture Capital
Menlo ParkSeed–Series B
4 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
3 people
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
JSD Capital, LLC
New YorkSeed–Growth$10M
8 people
IP Group
LondonSeed–Growth
2 people
Octave Ventures Llc
HendersonSeed–Late Stage
4 people
NEOM
RiyadhPre-Seed–Series C
15 people
Good Startup
BrusselsSeed–Late Stage
5 people
Aurelia Foundry
WellesleyPre-Seed–Late Stage
4 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.




























































